Hôpital Albert Michallon-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2017

  1. First-line ceritinib versus platinum-based chemotherapy in advanced ALK-rearranged non-small-cell lung cancer (ASCEND-4): a randomised, open-label, phase 3 study

    The Lancet, Vol. 389, Núm. 10072, pp. 917-929